Woodcock Shifts Focus To Operation Warp Speed, As Marks Steps Away

FDA drug center director Janet Woodcock is temporarily moving to the agency’s Office of the Commissioner as she goes on to oversee COVID-19 therapeutics development with the Trump administration’s Operation Warp Speed, which aims to speed development of COVID-19 vaccines and therapies. At the same time, biologics center director Peter Marks will step away from the administration’s vaccine project, which he helped stand up, FDA Commissioner Stephen Hahn said Friday (May 22). FDA drug center deputy director Patrizia Cavazzoni will...